tiprankstipranks
Intellia Therapeutics (NTLA)
NASDAQ:NTLA
US Market
NTLA
Intellia Therapeutics
RESEARCH TOOLSreports

Intellia Therapeutics (NTLA) Stock News & Sentiment

4,705 Followers
Balancing Reduced Regulatory Risk and Ongoing Development Uncertainty: Rationale for Maintaining a Hold Rating
Premium
Ratings
Balancing Reduced Regulatory Risk and Ongoing Development Uncertainty: Rationale for Maintaining a Hold Rating
1M ago
NTLA
Intellia Resumes Key Trial and Expands ATM Program
Premium
Company Announcements
Intellia Resumes Key Trial and Expands ATM Program
1M ago
8K
NTLA
Intellia Therapeutics Eyes 2026 Pivotal CRISPR Milestone
Premium
Company Announcements
Intellia Therapeutics Eyes 2026 Pivotal CRISPR Milestone
1M ago
NTLA
NTLA Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
NTLA Upcoming Earnings Report: What to Expect?
2M ago
NTLA
Intellia’s NTLA-2001 Hits Key Milestone in ATTR Gene-Editing Trial, Raising the Stakes in Amyloidosis
Premium
Company Announcements
Intellia’s NTLA-2001 Hits Key Milestone in ATTR Gene-Editing Trial, Raising the Stakes in Amyloidosis
2M ago
NTLA
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
2M ago
BA
GM
Intellia Therapeutics Stock (NTLA) Pops as FDA Lifts Safety Freeze on Nerve Disease Trial
Premium
Market News
Intellia Therapeutics Stock (NTLA) Pops as FDA Lifts Safety Freeze on Nerve Disease Trial
2M ago
NTLA
More NTLA News >

NTLA News on the Web

NTLA’s Lonvo-z Therapy Shows 96% Reduction in HAE Attacks: New Data Highlights Potential One-Time Treatment
Market Chameleon
Neutral
Bank of America Securities Reaffirms Their Hold Rating on Intellia Therapeutics (NTLA)
TipRanks News
Neutral
Take the Zacks Approach to Beat the Markets: LiveOne, Micron, Clorox in Focus
Zacks
Bullish
Take the Zacks Approach to Beat the Markets: Starbucks, Amgen, Allogene in Focus
Zacks
Bullish
NTLA Awards 16,500 RSUs to New Employees Under Strategic Inducement Plan
Market Chameleon
Neutral
This Cathie Wood Stock Is Up 47% This Year: Is It Too Late to Buy?
The Motley Fool
Neutral
Intellia Therapeutics (NTLA) Gets a Hold from Wedbush
TipRanks News
Neutral
Roblox initiated, Target upgraded: Wall Street’s top analyst calls
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
NTLA
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NTLA’s Media Buzz Sentiment?
1 articles about NTLA were published this week. In an average week, 1 articles are published.
    What is NTLA’s weekly average amount of articles?
    In an average week, 1 articles about NTLA are published.
      What is NTLA’s News Sentiment?
      50% of articles about NTLA were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        AORTArtivion
        HUMHumana
        ORGOOrganogenesis Holdings
        UNHUnitedHealth Group Incorporated Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S
        Showing the stocks with the most bullish news sentiment over the past week